These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9693880)

  • 21. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia.
    Mabuchi H; Fujii H; Calin G; Alder H; Negrini M; Rassenti L; Kipps TJ; Bullrich F; Croce CM
    Cancer Res; 2001 Apr; 61(7):2870-7. PubMed ID: 11306461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 13q14 deletions are not primary events in B-cell chronic lymphocytic leukemia: a study of 100 patients using fluorescence in situ hybridization.
    Avet-Loiseau H; Devilder MC; Garand R; Bouyge I; Rapp MJ; Milpied N; Harousseau JL; Moisan JP; Bataille R
    Clin Cancer Res; 1996 Oct; 2(10):1673-7. PubMed ID: 9816115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of 5'IGH deletions in B-cell chronic lymphocytic leukemia.
    Quintero-Rivera F; Nooraie F; Rao PN
    Cancer Genet Cytogenet; 2009 Apr; 190(1):33-9. PubMed ID: 19264231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
    Bièche I; Lidereau R
    Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.
    Lin K; Farahani M; Yang Y; Johnson GG; Oates M; Atherton M; Douglas A; Kalakonda N; Pettitt AR
    Br J Haematol; 2014 Nov; 167(3):346-55. PubMed ID: 25040181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
    Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
    Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: cytogenetic, FISH and clinical studies.
    Chena C; Avalos JS; Bezares RF; Arrossagaray G; Turdó K; Bistmans A; Slavutsky I
    Eur J Haematol; 2008 Aug; 81(2):94-9. PubMed ID: 18462257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance.
    Chung CY; Kantarjian H; Haidar M; Starostik P; Manshouri T; Gidel C; Freireich E; Keating M; Albitar M
    Cancer; 2000 Mar; 88(6):1359-64. PubMed ID: 10717617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
    Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
    Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
    Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
    Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12.
    Porpaczy E; Bilban M; Heinze G; Gruber M; Vanura K; Schwarzinger I; Stilgenbauer S; Streubel B; Fonatsch C; Jaeger U
    Eur J Clin Invest; 2009 Jul; 39(7):568-75. PubMed ID: 19453646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assignment of 48 ESTs to chromosome 13 band q14.3 and expression pattern for ESTs located in the core region deleted in B-CLL.
    Bézieau S; Devilder MC; Rondeau G; Cadoret E; Moisan JP; Moreau I
    Genomics; 1998 Sep; 52(3):369-73. PubMed ID: 9790756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukemia.
    Karhu R; Tobin G; Thunberg U; Vilpo L; Sundström C; Knuutila S; Rosenquist R; Vilpo J
    Genes Chromosomes Cancer; 2003 Aug; 37(4):417-20. PubMed ID: 12800154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis.
    Athanasiadou A; Stamatopoulos K; Tsompanakou A; Gaitatzi M; Kalogiannidis P; Anagnostopoulos A; Fassas A; Tsezou A
    Cancer Genet Cytogenet; 2006 Jul; 168(2):109-19. PubMed ID: 16843100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A cytological, immunophenotypical and cytogenetical study of 136 consecutive cases of B-cell chronic lymphoid hemopathies].
    Struski S; Leymarie V; Helias C; Falkenrodt A; Fohrer C; Audhuy B; Lioure B; Moskovtchenko P; Mazurier I; Galoisy AC; Gervais C; Mauvieux L; Herbrecht R; Bergerat JP; Lessard M
    Pathol Biol (Paris); 2007 Feb; 55(1):59-72. PubMed ID: 16690228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
    Kalla C; Scheuermann MO; Kube I; Schlotter M; Mertens D; Döhner H; Stilgenbauer S; Lichter P
    Eur J Cancer; 2007 May; 43(8):1328-35. PubMed ID: 17449237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic, fluorescence in situ hybridisation, and clinical evaluation of translocations with concomitant deletion at 13q14 in chronic lymphocytic leukaemia.
    Gardiner AC; Corcoran MM; Oscier DG
    Genes Chromosomes Cancer; 1997 Sep; 20(1):73-81. PubMed ID: 9290957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
    Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
    Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclinical chronic lymphocytic leukaemia associated with a 13q deletion presenting initially in the skin: apropos of a case.
    Khandelwal A; Seilstad KH; Magro CM
    J Cutan Pathol; 2006 Mar; 33(3):256-9. PubMed ID: 16466516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.